Table 3.

Association of baseline CKD awareness with changes in chronic disease management indicators and CKD progression at follow-up (N = 3,586).

	Mean Change at Follow-up if CKD Aware	Coefficient (95% CI) Unadjusted	p-value	Coefficient (95% CI) Model 1	p-value	Coefficient (95% CI) Model 2	p-value
Chronic Disease Management Indicators
Systolic BP (mm Hg)	−7.2	−2.25 (−5.75, 1.25)	0.206	0.19 (−3.20, 3.58)	0.910	−0.47 (−3.82, 2.88)	0.783
Fasting blood glucose (mg/dL)	−1.7	−3.48 (−10.9, 3.94)	0.357	2.03 (−5.38, 9.44)	0.590	−0.16 (−7.90, 7.57)	0.967
BMI (kg/m2)	−0.5	−1.46 (−22.0, 19.1)	0.888	−0.23 (−19.6 , 19.1)	0.981	−1.04 (−20.4, 18.3)	0.915
CKD Progression
eGFR (mL/min/1.73m2)	−17.1	0.17 (−3.27, 3.60)	0.924	−2.08 (−5.05, 0.88)	0.168	−2.79 (−5.72, 0.13)	0.061
UACR (mg/g)	−7.7	−54.0 (−1293, 1186)	0.931	153 (−957, 1263)	0.785	67.8 (−1018, 1153)	0.902

Model 1: Adjusted for eGFR and UACR.

Model 2: Adjusted for eGFR and UACR + age, sex, race, education, income, insurance status, marital status, urban status, region, hypertension, diabetes, coronary artery disease, stroke, family history of kidney disease, and baseline values of chronic disease management indicators.

Imputed data used for those who did not complete the follow-up in-home visit.

CKD – chronic kidney disease; CI – confidence interval; BP – blood pressure; BMI – body mass index; eGFR – estimated glomerular filtration rate; UACR – urine albumin-to-creatinine ratio.

Coefficients are the 10-year change in outcome associated with baseline CKD awareness.